A biochemical study of tardive dyskinesia in young male patients.
Based on specific criteria, tardive dyskinesia was diagnosed in 6 out of 29 young schizophrenic male inpatients. We compared several biochemical parameters in these six dyskinesia patients with those in six matched controls. The patients with dyskinesia had significantly lower platelet monoamine oxidase activity and significantly higher plasma dopamine-beta-hydroxylase activity as compared with the controls, thus confirming our previous findings in a population of elderly female inpatients. The dyskinetic and nondyskinetic groups did not differ from each other in mean whole blood serotonin concentration and mean serum neuroleptic concentration as measured with a radioreceptor binding assay. Possible significance of our results is discussed.
D000328:Adult; D014150:Antipsychotic Agents / Q000097:blood; D001792:Blood Platelets / Q000201:enzymology; D004299:Dopamine beta-Hydroxylase / Q000097:blood*; D004409:Dyskinesia, Drug-Induced / Q000201:enzymology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008995:Monoamine Oxidase / Q000097:blood*; D012559:Schizophrenia / Q000201:enzymology; D012701:Serotonin / Q000097:blood
D014150:Antipsychotic Agents; D012701:Serotonin; D004299:Dopamine beta-Hydroxylase; D008995:Monoamine Oxidase